ISC 2024 | Important debates in MeVO stroke

Johanna Ospel, MD, University of Calgary, Calgary, Alberta, Canada, shares her thoughts on the key questions that need addressing regarding medium vessel occlusion strokes (MeVOs). Elucidating the risk-benefit ratio of endovascular treatment (EVT) is a major area of investigation at the moment, with several ongoing trials assessing its use. As MeVOs are associated with improved functional outcomes compared to large vessel occlusion strokes and EVT in these smaller, more fragile vessels is more technically challenging, determining the threshold of symptom severity that justifies invasive treatment is important. The use of aspiration versus stent retriever thrombectomy in this setting is also unclear. This interview took place during the International Stroke Conference 2024 in Phoenix, AZ.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.